PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis from a Brazilian Private Perspective

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1394
https://www.valueinhealthjournal.com/article/S1098-3015(12)03107-5/fulltext
Title : PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis from a Brazilian Private Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03107-5&doi=10.1016/j.jval.2012.08.1394
First page : A446
Section Title : Muscular-Skeletal Disorders
Open access? : No
Section Order : 891
Categories :
Tags :
Regions :
ViH Article Tags :